Mutations in the GBA gene are present in an estimated 5–15% of Parkinson’s disease patients, underscoring its role as a substantial genetic component in the disease’s pathogenesis (Delamarre and Meissner, 2017). This evidence concerns the gene GBA1 and Parkinson disease.